AMI Organics Ltd. (ACUTAAS) Share Price Rises 2.37% Today; What the Move Signals
- September 1, 2026
- Posted by: Harsh Piplani
- Category: News
AMI Organics Ltd. Share Price traded at Rs 3,227.90 on 01 September 2026, up Rs 74.70 or 2.37% from the previous close of Rs 3,153.20. The stock opened at Rs 3,161.00, touched an intraday high of Rs 3,230.00, a low of Rs 3,161.00, and turnover stood at Rs 4.99 crore. Market capitalisation was Rs 26,870.92 crore.
The move stands out because the stock ended close to the day’s high, while the available dataset shows a company with premium valuation multiples but also stronger profitability than broad same-industry benchmarks. The supplied figures confirm the rise but do not establish a company-specific trigger, so the cleanest way to read today’s action is through price behaviour, valuation context and peer positioning.
AMI Organics Ltd. Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 3,227.9 |
| Previous Close | Rs 3,153.2 |
| Today's Move | Rs 74.7 (+2.37%) |
| Open | Rs 3,161 |
| High | Rs 3,230 |
| Low | Rs 3,161 |
| Turnover | Rs 4.99 crore |
| Market Capitalisation | Rs 26,870.92 crore |
| Market Cap Category | Large Cap |
AMI Organics Ltd. (ACUTAAS) rose to Rs 3,227.9 from the previous close of Rs 3,153.2, a move of Rs 74.7 or 2.37%. The stock opened at Rs 3,161, reached a high of Rs 3,230, recorded a low of Rs 3,161.
AMI Organics Ltd. Share Price moved from an opening level of Rs 3,161.00 to a high of Rs 3,230.00 and was quoted at Rs 3,227.90, only Rs 2.10 below the session high. The day low was also Rs 3,161.00, matching the open. That suggests the stock did not break below its opening level during the session captured by this dataset and instead spent the day moving upward.
Against the previous close of Rs 3,153.20, the stock gained Rs 74.70, or 2.37%. Turnover of Rs 4.99 crore indicates active trading interest, though not by itself a reason for the move. The most supportable short-term conclusion is simple: price strength was real, the stock held near the high, and traders tracking stocks rising today would have noticed it. Beyond that, the dataset does not justify speculation about news-driven catalysts.
AMI Organics Ltd. (ACUTAAS) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 26,870.92 crore |
| P/E Ratio | 66.84x |
| P/B Ratio | 14.93x |
| ROE | 24.08% |
| ROCE | 32.42% |
| EPS | Rs 47.17 |
| Book Value Per Share | Rs 211.13 |
| Dividend Yield | 0.08% |
AMI Organics Ltd. (ACUTAAS) fundamental metrics show P/E 66.84x, P/B 14.93x, ROE 24.08%, ROCE 32.42%. These figures provide context only and are not a buy or sell signal.
AMI Organics Ltd. has a market capitalisation of Rs 26870.92 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 66.84x, P/B at 14.93x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 24.08% and ROCE of 32.42%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 47.17, book value per share of Rs 211.13, dividend yield of 0.08%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 30.92x, median ROE of 11.81%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 66.84x |
| Benchmark Median P/E | 30.92x |
| Benchmark Average P/E | 48.02x |
| Benchmark P/E Range | 3.87x to 667.16x |
| Company P/B Ratio | 14.93x |
| Benchmark Median P/B | 2.88x |
| Company ROE | 24.08% |
| Benchmark Median ROE | 11.81% |
| Company ROCE | 32.42% |
| Benchmark Median ROCE | 13.65% |
| Company Market Capitalisation | Rs 26,870.92 crore |
| Benchmark Median Market Cap | Rs 683.05 crore |
AMI Organics Ltd. (ACUTAAS) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
AMI Organics Ltd. (ACUTAAS) has a P/E ratio of 66.84x, which is above the benchmark median of 30.92x, a difference of +116.17%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
AMI Organics Ltd. (ACUTAAS) has a ROE of 24.08%, which is above the benchmark median of 11.81%, a difference of +103.9%. AMI Organics Ltd. (ACUTAAS) has a ROCE of 32.42%, which is above the benchmark median of 13.65%, a difference of +137.51%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,60,696.31 | 38.8 | 5.43 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,46,062.83 | 83.91 | 13.89 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,91,515.22 | 86.82 | 21.1 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,18,403.7 | 25.69 | 4.3 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,14,554.33 | 33.94 | 3.25 | 11.83 | 16 |
AMI Organics Ltd. (ACUTAAS) has a P/E ratio of 66.84x compared with the displayed peer median of 38.8x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 24.08% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 32.42% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. AMI Organics Ltd. (ACUTAAS) has a market capitalisation of Rs 26,870.92 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching AMI Organics Ltd.
- AMI Organics Ltd. Share Price rose 2.37% to Rs 3,227.90 and stayed near the intraday high of Rs 3,230.00.
- Market cap of Rs 26,870.92 crore is above the industry average of Rs 14,252.9 crore and median of Rs 683.05 crore.
- P/E of 66.84 and P/B of 14.93 show a clear valuation premium versus the same-industry benchmark.
- ROE of 24.08% and ROCE of 32.42% are both ahead of industry medians and averages.
- ROCE also exceeds all five displayed pharma peers despite the company’s smaller size.
About AMI Organics Ltd.
Based on the supplied dataset, AMI Organics Ltd. is classified under Healthcare and Pharmaceuticals & Drugs. No additional business description is provided here, so the article is intentionally limited to market data, benchmark comparison and peer context.
Track AMI Organics Ltd. Share Price on Univest
Use AMI Organics Ltd. (ACUTAAS) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Readers can follow AMI Organics Ltd. (ACUTAAS) live share-price updates on Univest, along with the top gainers screener and market blogs. These pages help track price, market cap, valuation metrics, profitability ratios and broader sector context in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is AMI Organics Ltd. Share Price rising today?
Ans. AMI Organics Ltd. Share Price rose 2.37% today to Rs 3,227.90 from Rs 3,153.20, a gain of Rs 74.70. The supplied market data confirms the rise, but it does not identify a company-specific catalyst.
How does valuation compare with the industry?
Ans. The company trades at P/E 66.84 versus the same-industry median of 30.92 and average of 48.02. Its P/B is 14.93 versus the industry median of 2.88 and average of 4.34, indicating a premium valuation.
What do profitability metrics show?
Ans. ROE is 24.08% and ROCE is 32.42%. Both are above the same-industry medians of 11.81% and 13.65%, and above the averages of 11.21% and 13.76%. ROE stands at 24.08%. ROCE stands at 32.42%.
How does the company compare with major pharma peers?
Ans. AMI Organics Ltd. has a smaller market cap than Sun Pharma, Divi’s, Torrent, Zydus and Cipla. Its ROCE of 32.42% is higher than all five displayed peers, while its P/E is below Divi’s and Torrent but above Sun Pharma, Zydus.
